title: What steps can be taken to counter the increasing failure of miltefosine to treat visceral leishmaniasis?
authors: Shyam
authors: S
authors: Sundar
authors: Anup
authors: A
authors: Singh
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002985:Clinical Protocols; D003140:Communicable Disease Control / Q000639:trends; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007194:India; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D055118:Medication Adherence; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine